137 matches for your search in the start-up spotlight
rss
Results in seconds rather than hours: Groundbreaking instrument-free assay nears completion
14-Apr-2025
Chemeleon, a disruptive innovator in diagnostic technology, announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on ...
Successfully birthed an extinct species
10-Apr-2025
Colossal Biosciences, the world’s only de-extinction company, announces the rebirth of the once extinct dire wolf, the world’s first successfully de-extincted animal. The dire wolf, largely assumed to be a legendary creature made famous from the HBO hit series Game of Thrones, was an American ...
03-Apr-2025
Ecovative, the world's premier mycelium technology company, today announced it has secured over $11 million in its latest funding round to fuel the explosive growth of My®Bacon, the flagship product of Ecovative’s spinout company MyForest Foods. The investment comes as MyBacon rapidly expands its ...
11-Mar-2025
Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc. announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing ...
10-Mar-2025
Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round. This financing was led by Frazier Life Sciences with ...
“These tools reduce time, material usage and risk while enhancing process robustness and scalability”
04-Mar-2025
International process systems and operation experts have launched high-tech startupCrystallization Systems Technology Inc.(CrySyst) to streamline processes used by companies in the pharmaceutical and fine chemical industries. CrySyst’s quality-by-control (QbC) framework addresses ...
Colossal Secures $200M in Series C Funding From TWG Global
21-Jan-2025
Colossal Biosciences, the world’s first de-extinction company, has announced $200M in a Series C financing by TWG Global, a diversified holding company with operating businesses and investments in technology/AI, financial services, private lending and sports and media, jointly led by Mark Walter ...
Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells
20-Jan-2025
Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in the human body. Minovacca, recently incorporated by Janos Zempleni and Jiantao Guo, will ...
DMC seeking to transform how the world makes chemicals
16-Jan-2025
DMC Biotechnologies announced the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings more than 30 years of leadership experience in biotechnology and biomanufacturing. He has a proven track record of delivering commercial success through ...
ThirdLaw Molecular launches its groundbreaking platform for targeted drug discovery with a 4.5-billion molecule DNA-encoded library of Spiroligomer™ macromolecules
13-Jan-2025
ThirdLaw Molecular Inc., a targeted drug discovery biotech reimagining molecular therapeutics, announced the launch of its first DNA-encoded library of 4.5 billion Spiroligomer™ macromolecules. This library provides the Company and prospective partners access to a revolutionary category of ...
